CI Investments Inc’s Intellia Therapeutics NTLA Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | – | Sell |
-8,953
| Closed | -$64K | – | 1309 |
|
|
2025
Q1 | $64K | Sell |
8,953
-41
| -0.5% | -$293 | ﹤0.01% | 997 |
|
|
2024
Q4 | $105K | Buy |
8,994
+4,122
| +85% | +$48.1K | ﹤0.01% | 920 |
|
|
2024
Q3 | $100K | Buy |
4,872
+37
| +0.8% | +$759 | ﹤0.01% | 849 |
|
|
2024
Q2 | $108K | Buy |
4,835
+997
| +26% | +$22.3K | ﹤0.01% | 791 |
|
|
2024
Q1 | $106K | Buy |
3,838
+3
| +0.1% | +$83 | ﹤0.01% | 877 |
|
|
2023
Q4 | $117K | Buy |
3,835
+1,204
| +46% | +$36.7K | ﹤0.01% | 793 |
|
|
2023
Q3 | $83K | Sell |
2,631
-79
| -3% | -$2.49K | ﹤0.01% | 861 |
|
|
2023
Q2 | $111K | Buy |
2,710
+340
| +14% | +$13.9K | ﹤0.01% | 761 |
|
|
2023
Q1 | $88K | Sell |
2,370
-30
| -1% | -$1.11K | ﹤0.01% | 767 |
|
|
2022
Q4 | $84K | Buy |
2,400
+2,011
| +517% | +$70.4K | ﹤0.01% | 792 |
|
|
2022
Q3 | $22K | Sell |
389
-28
| -7% | -$1.58K | ﹤0.01% | 1007 |
|
|
2022
Q2 | $22K | Sell |
417
-147
| -26% | -$7.76K | ﹤0.01% | 960 |
|
|
2022
Q1 | $41K | Buy |
564
+207
| +58% | +$15K | ﹤0.01% | 981 |
|
|
2021
Q4 | $42K | Buy |
357
+70
| +24% | +$8.24K | ﹤0.01% | 1023 |
|
|
2021
Q3 | $39K | Buy |
+287
| New | +$39K | ﹤0.01% | 1000 |
|